Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 8306

In scope icon N/A E
QID 8306 (Type "8306" in App Search)
What human bone disease would result from loss of osteoprotegrin (OPG) protein?

Multiple hereditary exostosis

2%

2/82

Osteomalacia

6%

5/82

Osteopetrosis

26%

21/82

Osteoporosis

63%

52/82

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

Loss of function of the OPG gene results in osteoporosis. Osteoprotegrin binds receptor activator of nuclear factor kappa beta (RANK) and inhibits its binding to RANK ligand (RANKL) on osteoclasts. An individual with this mutation would no longer have a way to block RANKL on osteoblasts from binding to RANK on osteoclasts. Osteoclasts would be constitutively activated, resulting in uncontrolled bone resorption. Several mouse models have confirmed the presence of this condition in knock-out mice. Multiple hereditary exostosis is an autosomal-dominant condition that results in osteochondroma formation. It has been linked to defects in the EXT1, EXT2, and EXT3 genes. Osteopetrosis would develop if a patient had overexpression of OPG or a carbonic anhydrase deficiency. Osteomalacia is the result of a deficiency in osteoid mineralization most commonly attributable to vitamin D deficiency.

REFERENCES (2)
Authors
Rating
Please Rate Question Quality

3.5

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(10)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options